In stage III , RFS was slightly better for patients with MSI-H CC ( HR 0.67 , 95 % CI 0.46-0 .99 , P = 0.04 ) , but the difference was not statistically significant for OS ( HR 0.70 , 95 % CI 0.44-1 .09 , P = 0.11 ) .